Revolution Medicines (RVMD) Change in Accured Expenses (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Change in Accured Expenses of -$16.7 million for Q1 2026, down 1180.63% year-over-year from $1.5 million in Q1 2025, and down 130.66% quarter-over-quarter from $54.6 million in Q4 2025.
Revolution Medicines (RVMD) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Revolution Medicines' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$16.7 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 1180.63% year-over-year to -$16.7 million; the TTM figure through Mar 2026 stood at $94.0 million (up 109.81% YoY), while the FY2025 annual figure was $112.3 million, up 410.65% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$16.7 million, down from $54.6 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $54.6 million in Q4 2025, with the low at -$21.3 million in Q1 2024.
- The 5-year median for Change in Accured Expenses is $7.6 million (2023), against an average of $7.9 million.
- The sharpest annual moves came in 2023 and 2026: Change in Accured Expenses soared 685.1% in 2023, then tumbled 1180.63% in 2026.
- Revolution Medicines' Change in Accured Expenses stood at -$3.0 million in 2022, then sank by 112.1% to -$6.3 million in 2023, then surged by 390.86% to $18.3 million in 2024, then surged by 198.42% to $54.6 million in 2025, then sank by 130.66% to -$16.7 million in 2026.
- Business Quant data shows RVMD's Change in Accured Expenses at -$16.7 million in Q1 2026, $54.6 million in Q4 2025, and $45.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -13.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.78 Mn |
| Jun 30, 2026 | 55.78 Mn |
| Mar 31, 2026 | -16.74 Mn |
| Mar 31, 2026 | -16.74 Mn |
| Dec 31, 2025 | 54.60 Mn |
| Dec 31, 2025 | 54.60 Mn |
| Sep 30, 2025 | 45.29 Mn |
| Sep 30, 2025 | 45.29 Mn |
| Jun 30, 2025 | 10.82 Mn |
| Jun 30, 2025 | 10.82 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 18.30 Mn |
| Dec 31, 2024 | 18.30 Mn |
| Sep 30, 2024 | 10.28 Mn |
| Sep 30, 2024 | 10.28 Mn |
| Jun 30, 2024 | 14.67 Mn |
| Jun 30, 2024 | 14.67 Mn |
| Mar 31, 2024 | -21.26 Mn |
| Mar 31, 2024 | -21.26 Mn |